The integrity test on the final sterilizing filter for parental products is required to be implemented in situ. However, it is hard to do because they’re a big facility consisting of many cartridges. Is an off line test instead of an in situ test acceptable?
Q7A does not address sterile APIs. Once the API has been sterilized, then all the aseptic manipulation downstream would be covered under drug product GMPs.
